UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________________________________
FORM 8-A
__________________________________________________
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF
THE SECURITIES EXCHANGE ACT OF 1934
| Healthcare Triangle, Inc. |
| (Exact name of registrant as specified in its charter) |
| Delaware | 84-3559776 | |
| (State or other jurisdiction of incorporation) | (IRS Employer Identification Number) |
4309 Hacienda Dr., Suite 150
Pleasanton, California 94588
(925) 270-4812
(Address of principal executive offices and zip code)
Copies To:
Ross D. Carmel, Esq.
Jeffrey P. Wofford, Esq.
Carmel, Milazzo & Feil LLP
55 West 39th Street, 18th Floor
New York, New York 10018
Telephone: (212) 658-0458
Securities to be registered pursuant to Section 12(b) of the Exchange Act:
Title of each class to be registered | Name of each exchange on which each class is to be registered | |
| Common Stock, par value $0.00001 per share | The NASDAQ Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ☐
Securities Act registration statement file number to which this form relates: 333-259180
Securities to be registered pursuant to Section 12(g) of the Act: None
| 1 |
Item 1. Description of Registrant’s Securities to be Registered.
Common Stock
The description of the common stock, par value $0.00001 per share, of Healthcare Triangle, Inc., a Delaware corporation (the “Registrant”), to be registered hereunder is contained in the section entitled “Description of Securities” in the Registrant’s Registration Statement on Form S-1 (File No. 333-259180), as filed with the Securities and Exchange Commission (the “Commission”) on August 30, 2021 and thereafter amended and declared effective by the Commission on October 12, 2021 (the “Registration Statement”), is incorporated herein by reference. Any prospectus that constitutes part of the Registration Statement and that is subsequently filed by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be herein incorporated by reference.
Item 2. Exhibits
Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
| 2 |
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Healthcare Triangle, Inc. | ||
| Dated: October 12, 2021 | By: | /s/Suresh Venkatachari |
| Name: Suresh Venkatachari | ||
| Title: Chief Executive Officer | ||
| 3 |
